Alemtuzumab Intravenous and Kitabis Pak inhalation
Determining the interaction of Alemtuzumab Intravenous and Kitabis Pak inhalation and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: alemtuzumab
Brand name: Campath, Lemtrada
Synonyms: Alemtuzumab
Generic Name: tobramycin
Brand name: Bethkis, Kitabis Pak, Tobi, TOBI Podhaler
Synonyms: Kitabis Pak (inhalation), Kitabis Pak
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Alemtuzumab Intravenous-Klofensaid II
- Alemtuzumab Intravenous-Klonopin
- Alemtuzumab Intravenous-Klonopin Wafer
- Alemtuzumab Intravenous-Klonopin Wafers
- Alemtuzumab Intravenous-Klor-Con
- Alemtuzumab Intravenous-Klor-Con M
- Kitabis Pak inhalation-Alenaze-D
- Kitabis Pak inhalation-Alendronate
- Kitabis Pak inhalation-Alendronate and cholecalciferol
- Kitabis Pak inhalation-Alendronate Effervescent Tablets
- Kitabis Pak inhalation-Alendronate Oral Solution
- Kitabis Pak inhalation-Alendronate Sodium